nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine—ADORA2B—Pentoxifylline—systemic scleroderma	0.357	0.423	CbGbCtD
Adenosine—ADORA1—Pentoxifylline—systemic scleroderma	0.258	0.306	CbGbCtD
Adenosine—ADORA2A—Pentoxifylline—systemic scleroderma	0.228	0.271	CbGbCtD
Adenosine—DPP4—blood vessel—systemic scleroderma	0.00298	0.104	CbGeAlD
Adenosine—SLC28A3—digestive system—systemic scleroderma	0.00214	0.0743	CbGeAlD
Adenosine—ADORA2B—smooth muscle tissue—systemic scleroderma	0.00193	0.0671	CbGeAlD
Adenosine—ADA—connective tissue—systemic scleroderma	0.00193	0.067	CbGeAlD
Adenosine—SLC28A3—lung—systemic scleroderma	0.00178	0.0621	CbGeAlD
Adenosine—Glucosamine—MMP9—systemic scleroderma	0.00164	1	CrCbGaD
Adenosine—DPP4—connective tissue—systemic scleroderma	0.00153	0.0531	CbGeAlD
Adenosine—ADK—smooth muscle tissue—systemic scleroderma	0.00144	0.0501	CbGeAlD
Adenosine—ADK—skin of body—systemic scleroderma	0.00142	0.0495	CbGeAlD
Adenosine—DPP4—smooth muscle tissue—systemic scleroderma	0.0014	0.0486	CbGeAlD
Adenosine—ADA—digestive system—systemic scleroderma	0.00139	0.0484	CbGeAlD
Adenosine—ADA—tendon—systemic scleroderma	0.00133	0.0461	CbGeAlD
Adenosine—ADORA2B—lung—systemic scleroderma	0.00127	0.0442	CbGeAlD
Adenosine—ADA—lung—systemic scleroderma	0.00116	0.0404	CbGeAlD
Adenosine—DPP4—digestive system—systemic scleroderma	0.0011	0.0384	CbGeAlD
Adenosine—ADK—tendon—systemic scleroderma	0.00108	0.0377	CbGeAlD
Adenosine—DPP4—tendon—systemic scleroderma	0.00105	0.0365	CbGeAlD
Adenosine—ADORA1—tendon—systemic scleroderma	0.00104	0.0362	CbGeAlD
Adenosine—ADK—lung—systemic scleroderma	0.00095	0.033	CbGeAlD
Adenosine—DPP4—lung—systemic scleroderma	0.000921	0.032	CbGeAlD
Adenosine—ADORA1—lung—systemic scleroderma	0.000914	0.0318	CbGeAlD
Adenosine—Anaphylactic shock—Captopril—systemic scleroderma	0.000322	0.00256	CcSEcCtD
Adenosine—Mediastinal disorder—Mycophenolic acid—systemic scleroderma	0.000321	0.00255	CcSEcCtD
Adenosine—Dysgeusia—Leflunomide—systemic scleroderma	0.000318	0.00253	CcSEcCtD
Adenosine—Arrhythmia—Mycophenolic acid—systemic scleroderma	0.000318	0.00253	CcSEcCtD
Adenosine—Shock—Captopril—systemic scleroderma	0.000317	0.00252	CcSEcCtD
Adenosine—Back pain—Leflunomide—systemic scleroderma	0.000314	0.0025	CcSEcCtD
Adenosine—Tachycardia—Captopril—systemic scleroderma	0.000314	0.0025	CcSEcCtD
Adenosine—Pain—Mometasone—systemic scleroderma	0.000313	0.00249	CcSEcCtD
Adenosine—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000313	0.00249	CcSEcCtD
Adenosine—Acute coronary syndrome—Mycophenolate mofetil—systemic scleroderma	0.000309	0.00245	CcSEcCtD
Adenosine—Myocardial infarction—Mycophenolate mofetil—systemic scleroderma	0.000307	0.00244	CcSEcCtD
Adenosine—Vision blurred—Leflunomide—systemic scleroderma	0.000306	0.00243	CcSEcCtD
Adenosine—Asthenia—Pentoxifylline—systemic scleroderma	0.000305	0.00242	CcSEcCtD
Adenosine—Tension—Mycophenolic acid—systemic scleroderma	0.000304	0.00242	CcSEcCtD
Adenosine—Nervousness—Mycophenolic acid—systemic scleroderma	0.000301	0.00239	CcSEcCtD
Adenosine—Hypotension—Captopril—systemic scleroderma	0.000301	0.00239	CcSEcCtD
Adenosine—Sweating—Mycophenolate mofetil—systemic scleroderma	0.0003	0.00239	CcSEcCtD
Adenosine—Back pain—Mycophenolic acid—systemic scleroderma	0.0003	0.00238	CcSEcCtD
Adenosine—Tinnitus—Lisinopril—systemic scleroderma	0.000299	0.00238	CcSEcCtD
Adenosine—Flushing—Lisinopril—systemic scleroderma	0.000298	0.00237	CcSEcCtD
Adenosine—Angioedema—Leflunomide—systemic scleroderma	0.000297	0.00236	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.000293	0.00233	CcSEcCtD
Adenosine—Vision blurred—Mycophenolic acid—systemic scleroderma	0.000292	0.00232	CcSEcCtD
Adenosine—Tremor—Mycophenolic acid—systemic scleroderma	0.00029	0.00231	CcSEcCtD
Adenosine—Discomfort—Azathioprine—systemic scleroderma	0.000289	0.0023	CcSEcCtD
Adenosine—Mediastinal disorder—Lisinopril—systemic scleroderma	0.000289	0.0023	CcSEcCtD
Adenosine—Paraesthesia—Captopril—systemic scleroderma	0.000289	0.0023	CcSEcCtD
Adenosine—Palpitations—Leflunomide—systemic scleroderma	0.000287	0.00228	CcSEcCtD
Adenosine—Dyspnoea—Captopril—systemic scleroderma	0.000287	0.00228	CcSEcCtD
Adenosine—Arrhythmia—Lisinopril—systemic scleroderma	0.000287	0.00228	CcSEcCtD
Adenosine—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.000286	0.00227	CcSEcCtD
Adenosine—Somnolence—Captopril—systemic scleroderma	0.000286	0.00227	CcSEcCtD
Adenosine—Agitation—Mycophenolic acid—systemic scleroderma	0.000285	0.00226	CcSEcCtD
Adenosine—Cough—Leflunomide—systemic scleroderma	0.000284	0.00225	CcSEcCtD
Adenosine—Cardiac failure—Prednisone—systemic scleroderma	0.000282	0.00224	CcSEcCtD
Adenosine—Dizziness—Pentoxifylline—systemic scleroderma	0.000281	0.00223	CcSEcCtD
Adenosine—Hypertension—Leflunomide—systemic scleroderma	0.000281	0.00223	CcSEcCtD
Adenosine—Hypoaesthesia—Mycophenolate mofetil—systemic scleroderma	0.00028	0.00222	CcSEcCtD
Adenosine—Syncope—Mycophenolic acid—systemic scleroderma	0.000278	0.00221	CcSEcCtD
Adenosine—Chest pain—Leflunomide—systemic scleroderma	0.000277	0.0022	CcSEcCtD
Adenosine—Anxiety—Leflunomide—systemic scleroderma	0.000276	0.00219	CcSEcCtD
Adenosine—Tension—Lisinopril—systemic scleroderma	0.000274	0.00218	CcSEcCtD
Adenosine—Palpitations—Mycophenolic acid—systemic scleroderma	0.000274	0.00218	CcSEcCtD
Adenosine—Dysgeusia—Lisinopril—systemic scleroderma	0.000273	0.00217	CcSEcCtD
Adenosine—Discomfort—Leflunomide—systemic scleroderma	0.000273	0.00217	CcSEcCtD
Adenosine—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.000273	0.00217	CcSEcCtD
Adenosine—Nervousness—Lisinopril—systemic scleroderma	0.000271	0.00216	CcSEcCtD
Adenosine—Affect lability—Prednisone—systemic scleroderma	0.000271	0.00215	CcSEcCtD
Adenosine—Dry mouth—Leflunomide—systemic scleroderma	0.000271	0.00215	CcSEcCtD
Adenosine—Cough—Mycophenolic acid—systemic scleroderma	0.000271	0.00215	CcSEcCtD
Adenosine—Back pain—Lisinopril—systemic scleroderma	0.00027	0.00215	CcSEcCtD
Adenosine—Vomiting—Pentoxifylline—systemic scleroderma	0.00027	0.00215	CcSEcCtD
Adenosine—Convulsion—Mycophenolic acid—systemic scleroderma	0.000269	0.00213	CcSEcCtD
Adenosine—Rash—Pentoxifylline—systemic scleroderma	0.000268	0.00213	CcSEcCtD
Adenosine—Hypertension—Mycophenolic acid—systemic scleroderma	0.000268	0.00213	CcSEcCtD
Adenosine—Dermatitis—Pentoxifylline—systemic scleroderma	0.000268	0.00213	CcSEcCtD
Adenosine—Headache—Pentoxifylline—systemic scleroderma	0.000266	0.00211	CcSEcCtD
Adenosine—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000265	0.00211	CcSEcCtD
Adenosine—Chest pain—Mycophenolic acid—systemic scleroderma	0.000264	0.0021	CcSEcCtD
Adenosine—Vision blurred—Lisinopril—systemic scleroderma	0.000263	0.00209	CcSEcCtD
Adenosine—Anxiety—Mycophenolic acid—systemic scleroderma	0.000263	0.00209	CcSEcCtD
Adenosine—Asthenia—Mometasone—systemic scleroderma	0.000263	0.00209	CcSEcCtD
Adenosine—Hypotension—Azathioprine—systemic scleroderma	0.000262	0.00209	CcSEcCtD
Adenosine—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.000262	0.00208	CcSEcCtD
Adenosine—Cardiac arrest—Prednisone—systemic scleroderma	0.000262	0.00208	CcSEcCtD
Adenosine—Tremor—Lisinopril—systemic scleroderma	0.000262	0.00208	CcSEcCtD
Adenosine—Mood swings—Prednisone—systemic scleroderma	0.000261	0.00207	CcSEcCtD
Adenosine—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.000261	0.00207	CcSEcCtD
Adenosine—Discomfort—Mycophenolic acid—systemic scleroderma	0.000261	0.00207	CcSEcCtD
Adenosine—Tachycardia—Leflunomide—systemic scleroderma	0.000259	0.00206	CcSEcCtD
Adenosine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000258	0.00205	CcSEcCtD
Adenosine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000256	0.00204	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000256	0.00203	CcSEcCtD
Adenosine—Angioedema—Lisinopril—systemic scleroderma	0.000255	0.00203	CcSEcCtD
Adenosine—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000253	0.00201	CcSEcCtD
Adenosine—Nausea—Pentoxifylline—systemic scleroderma	0.000252	0.002	CcSEcCtD
Adenosine—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.000251	0.002	CcSEcCtD
Adenosine—Syncope—Lisinopril—systemic scleroderma	0.00025	0.00199	CcSEcCtD
Adenosine—Shock—Mycophenolic acid—systemic scleroderma	0.000249	0.00198	CcSEcCtD
Adenosine—Hypotension—Leflunomide—systemic scleroderma	0.000248	0.00197	CcSEcCtD
Adenosine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000247	0.00196	CcSEcCtD
Adenosine—Palpitations—Lisinopril—systemic scleroderma	0.000247	0.00196	CcSEcCtD
Adenosine—Loss of consciousness—Lisinopril—systemic scleroderma	0.000245	0.00195	CcSEcCtD
Adenosine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000245	0.00194	CcSEcCtD
Adenosine—Cough—Lisinopril—systemic scleroderma	0.000244	0.00194	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000242	0.00192	CcSEcCtD
Adenosine—Tension—Mycophenolate mofetil—systemic scleroderma	0.00024	0.00191	CcSEcCtD
Adenosine—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.00024	0.0019	CcSEcCtD
Adenosine—Paraesthesia—Leflunomide—systemic scleroderma	0.000238	0.00189	CcSEcCtD
Adenosine—Chest pain—Lisinopril—systemic scleroderma	0.000238	0.00189	CcSEcCtD
Adenosine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000238	0.00189	CcSEcCtD
Adenosine—Anxiety—Lisinopril—systemic scleroderma	0.000237	0.00188	CcSEcCtD
Adenosine—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000237	0.00188	CcSEcCtD
Adenosine—Dyspnoea—Leflunomide—systemic scleroderma	0.000236	0.00188	CcSEcCtD
Adenosine—Hypotension—Mycophenolic acid—systemic scleroderma	0.000236	0.00188	CcSEcCtD
Adenosine—Discomfort—Lisinopril—systemic scleroderma	0.000235	0.00187	CcSEcCtD
Adenosine—Cerebrovascular accident—Methotrexate—systemic scleroderma	0.000235	0.00187	CcSEcCtD
Adenosine—Vomiting—Mometasone—systemic scleroderma	0.000233	0.00185	CcSEcCtD
Adenosine—Dry mouth—Lisinopril—systemic scleroderma	0.000233	0.00185	CcSEcCtD
Adenosine—Rash—Mometasone—systemic scleroderma	0.000231	0.00184	CcSEcCtD
Adenosine—Asthenia—Captopril—systemic scleroderma	0.000231	0.00184	CcSEcCtD
Adenosine—Dermatitis—Mometasone—systemic scleroderma	0.000231	0.00183	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000231	0.00183	CcSEcCtD
Adenosine—Headache—Mometasone—systemic scleroderma	0.00023	0.00182	CcSEcCtD
Adenosine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000229	0.00182	CcSEcCtD
Adenosine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000228	0.00181	CcSEcCtD
Adenosine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000227	0.00181	CcSEcCtD
Adenosine—Pain—Leflunomide—systemic scleroderma	0.000227	0.0018	CcSEcCtD
Adenosine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000226	0.00179	CcSEcCtD
Adenosine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000225	0.00179	CcSEcCtD
Adenosine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000225	0.00179	CcSEcCtD
Adenosine—Shock—Lisinopril—systemic scleroderma	0.000224	0.00178	CcSEcCtD
Adenosine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000224	0.00178	CcSEcCtD
Adenosine—Tachycardia—Lisinopril—systemic scleroderma	0.000222	0.00177	CcSEcCtD
Adenosine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00022	0.00175	CcSEcCtD
Adenosine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000219	0.00174	CcSEcCtD
Adenosine—Mood swings—Methotrexate—systemic scleroderma	0.000218	0.00173	CcSEcCtD
Adenosine—Nausea—Mometasone—systemic scleroderma	0.000218	0.00173	CcSEcCtD
Adenosine—Pain—Mycophenolic acid—systemic scleroderma	0.000216	0.00172	CcSEcCtD
Adenosine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000216	0.00172	CcSEcCtD
Adenosine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000215	0.00171	CcSEcCtD
Adenosine—Cough—Mycophenolate mofetil—systemic scleroderma	0.000214	0.0017	CcSEcCtD
Adenosine—Hypotension—Lisinopril—systemic scleroderma	0.000213	0.00169	CcSEcCtD
Adenosine—Dizziness—Captopril—systemic scleroderma	0.000213	0.00169	CcSEcCtD
Adenosine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000212	0.00168	CcSEcCtD
Adenosine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000211	0.00168	CcSEcCtD
Adenosine—Urticaria—Leflunomide—systemic scleroderma	0.000211	0.00167	CcSEcCtD
Adenosine—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000209	0.00166	CcSEcCtD
Adenosine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000208	0.00166	CcSEcCtD
Adenosine—Myocardial infarction—Prednisone—systemic scleroderma	0.000208	0.00165	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000208	0.00165	CcSEcCtD
Adenosine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000208	0.00165	CcSEcCtD
Adenosine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000207	0.00164	CcSEcCtD
Adenosine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000206	0.00164	CcSEcCtD
Adenosine—Paraesthesia—Lisinopril—systemic scleroderma	0.000205	0.00163	CcSEcCtD
Adenosine—Vomiting—Captopril—systemic scleroderma	0.000205	0.00163	CcSEcCtD
Adenosine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000204	0.00162	CcSEcCtD
Adenosine—Dyspnoea—Lisinopril—systemic scleroderma	0.000203	0.00161	CcSEcCtD
Adenosine—Rash—Captopril—systemic scleroderma	0.000203	0.00161	CcSEcCtD
Adenosine—Dermatitis—Captopril—systemic scleroderma	0.000203	0.00161	CcSEcCtD
Adenosine—Somnolence—Lisinopril—systemic scleroderma	0.000203	0.00161	CcSEcCtD
Adenosine—Headache—Captopril—systemic scleroderma	0.000202	0.0016	CcSEcCtD
Adenosine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.0002	0.00159	CcSEcCtD
Adenosine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000196	0.00156	CcSEcCtD
Adenosine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000195	0.00155	CcSEcCtD
Adenosine—Pain—Lisinopril—systemic scleroderma	0.000195	0.00155	CcSEcCtD
Adenosine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000195	0.00155	CcSEcCtD
Adenosine—Bradycardia—Prednisone—systemic scleroderma	0.000194	0.00154	CcSEcCtD
Adenosine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000193	0.00153	CcSEcCtD
Adenosine—Nausea—Captopril—systemic scleroderma	0.000191	0.00152	CcSEcCtD
Adenosine—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000191	0.00152	CcSEcCtD
Adenosine—Asthenia—Leflunomide—systemic scleroderma	0.00019	0.00151	CcSEcCtD
Adenosine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000187	0.00148	CcSEcCtD
Adenosine—Dizziness—Azathioprine—systemic scleroderma	0.000186	0.00148	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000182	0.00145	CcSEcCtD
Adenosine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000182	0.00144	CcSEcCtD
Adenosine—Urticaria—Lisinopril—systemic scleroderma	0.000181	0.00144	CcSEcCtD
Adenosine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000179	0.00143	CcSEcCtD
Adenosine—Vomiting—Azathioprine—systemic scleroderma	0.000179	0.00142	CcSEcCtD
Adenosine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000178	0.00141	CcSEcCtD
Adenosine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000178	0.00141	CcSEcCtD
Adenosine—Drowsiness—Methotrexate—systemic scleroderma	0.000177	0.00141	CcSEcCtD
Adenosine—Rash—Azathioprine—systemic scleroderma	0.000177	0.00141	CcSEcCtD
Adenosine—Dermatitis—Azathioprine—systemic scleroderma	0.000177	0.00141	CcSEcCtD
Adenosine—Flushing—Prednisone—systemic scleroderma	0.000177	0.00141	CcSEcCtD
Adenosine—Headache—Azathioprine—systemic scleroderma	0.000176	0.0014	CcSEcCtD
Adenosine—Dizziness—Leflunomide—systemic scleroderma	0.000175	0.00139	CcSEcCtD
Adenosine—Pain—Mycophenolate mofetil—systemic scleroderma	0.000171	0.00136	CcSEcCtD
Adenosine—Arrhythmia—Prednisone—systemic scleroderma	0.00017	0.00135	CcSEcCtD
Adenosine—Sweating—Methotrexate—systemic scleroderma	0.00017	0.00135	CcSEcCtD
Adenosine—Vomiting—Leflunomide—systemic scleroderma	0.000169	0.00134	CcSEcCtD
Adenosine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000168	0.00133	CcSEcCtD
Adenosine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000167	0.00133	CcSEcCtD
Adenosine—Rash—Leflunomide—systemic scleroderma	0.000167	0.00133	CcSEcCtD
Adenosine—Dermatitis—Leflunomide—systemic scleroderma	0.000167	0.00133	CcSEcCtD
Adenosine—Nausea—Azathioprine—systemic scleroderma	0.000167	0.00133	CcSEcCtD
Adenosine—Headache—Leflunomide—systemic scleroderma	0.000166	0.00132	CcSEcCtD
Adenosine—Asthenia—Lisinopril—systemic scleroderma	0.000164	0.0013	CcSEcCtD
Adenosine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000161	0.00128	CcSEcCtD
Adenosine—Rash—Mycophenolic acid—systemic scleroderma	0.00016	0.00127	CcSEcCtD
Adenosine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000159	0.00127	CcSEcCtD
Adenosine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000159	0.00126	CcSEcCtD
Adenosine—Headache—Mycophenolic acid—systemic scleroderma	0.000159	0.00126	CcSEcCtD
Adenosine—Nausea—Leflunomide—systemic scleroderma	0.000158	0.00125	CcSEcCtD
Adenosine—Vision blurred—Prednisone—systemic scleroderma	0.000156	0.00124	CcSEcCtD
Adenosine—Agitation—Prednisone—systemic scleroderma	0.000152	0.00121	CcSEcCtD
Adenosine—Angioedema—Prednisone—systemic scleroderma	0.000152	0.0012	CcSEcCtD
Adenosine—Dizziness—Lisinopril—systemic scleroderma	0.000151	0.0012	CcSEcCtD
Adenosine—Nausea—Mycophenolic acid—systemic scleroderma	0.00015	0.00119	CcSEcCtD
Adenosine—Syncope—Prednisone—systemic scleroderma	0.000149	0.00118	CcSEcCtD
Adenosine—Tinnitus—Methotrexate—systemic scleroderma	0.000148	0.00118	CcSEcCtD
Adenosine—Cardiac disorder—Methotrexate—systemic scleroderma	0.000148	0.00117	CcSEcCtD
Adenosine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000147	0.00117	CcSEcCtD
Adenosine—Loss of consciousness—Prednisone—systemic scleroderma	0.000146	0.00116	CcSEcCtD
Adenosine—Vomiting—Lisinopril—systemic scleroderma	0.000145	0.00115	CcSEcCtD
Adenosine—Rash—Lisinopril—systemic scleroderma	0.000144	0.00114	CcSEcCtD
Adenosine—Convulsion—Prednisone—systemic scleroderma	0.000144	0.00114	CcSEcCtD
Adenosine—Dermatitis—Lisinopril—systemic scleroderma	0.000144	0.00114	CcSEcCtD
Adenosine—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000144	0.00114	CcSEcCtD
Adenosine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000143	0.00114	CcSEcCtD
Adenosine—Hypertension—Prednisone—systemic scleroderma	0.000143	0.00114	CcSEcCtD
Adenosine—Headache—Lisinopril—systemic scleroderma	0.000143	0.00113	CcSEcCtD
Adenosine—Anxiety—Prednisone—systemic scleroderma	0.000141	0.00112	CcSEcCtD
Adenosine—Discomfort—Prednisone—systemic scleroderma	0.00014	0.00111	CcSEcCtD
Adenosine—Dysgeusia—Methotrexate—systemic scleroderma	0.000136	0.00108	CcSEcCtD
Adenosine—Nausea—Lisinopril—systemic scleroderma	0.000135	0.00108	CcSEcCtD
Adenosine—Anaphylactic shock—Prednisone—systemic scleroderma	0.000135	0.00108	CcSEcCtD
Adenosine—Back pain—Methotrexate—systemic scleroderma	0.000134	0.00107	CcSEcCtD
Adenosine—Shock—Prednisone—systemic scleroderma	0.000133	0.00106	CcSEcCtD
Adenosine—Tachycardia—Prednisone—systemic scleroderma	0.000132	0.00105	CcSEcCtD
Adenosine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000132	0.00105	CcSEcCtD
Adenosine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000131	0.00104	CcSEcCtD
Adenosine—Vision blurred—Methotrexate—systemic scleroderma	0.000131	0.00104	CcSEcCtD
Adenosine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000127	0.00101	CcSEcCtD
Adenosine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000126	0.001	CcSEcCtD
Adenosine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000126	0.001	CcSEcCtD
Adenosine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000125	0.000994	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000123	0.00098	CcSEcCtD
Adenosine—Paraesthesia—Prednisone—systemic scleroderma	0.000122	0.000966	CcSEcCtD
Adenosine—Cough—Methotrexate—systemic scleroderma	0.000121	0.000961	CcSEcCtD
Adenosine—Convulsion—Methotrexate—systemic scleroderma	0.00012	0.000954	CcSEcCtD
Adenosine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000119	0.000943	CcSEcCtD
Adenosine—Chest pain—Methotrexate—systemic scleroderma	0.000118	0.000938	CcSEcCtD
Adenosine—Discomfort—Methotrexate—systemic scleroderma	0.000117	0.000927	CcSEcCtD
Adenosine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000113	0.000899	CcSEcCtD
Adenosine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000109	0.000869	CcSEcCtD
Adenosine—Urticaria—Prednisone—systemic scleroderma	0.000108	0.000855	CcSEcCtD
Adenosine—Hypotension—Methotrexate—systemic scleroderma	0.000106	0.00084	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000103	0.000819	CcSEcCtD
Adenosine—Paraesthesia—Methotrexate—systemic scleroderma	0.000102	0.000807	CcSEcCtD
Adenosine—Dyspnoea—Methotrexate—systemic scleroderma	0.000101	0.000802	CcSEcCtD
Adenosine—Somnolence—Methotrexate—systemic scleroderma	0.000101	0.000799	CcSEcCtD
Adenosine—Hypersensitivity—Prednisone—systemic scleroderma	9.97e-05	0.000793	CcSEcCtD
Adenosine—Asthenia—Prednisone—systemic scleroderma	9.71e-05	0.000772	CcSEcCtD
Adenosine—Pain—Methotrexate—systemic scleroderma	9.67e-05	0.000769	CcSEcCtD
Adenosine—Urticaria—Methotrexate—systemic scleroderma	8.99e-05	0.000714	CcSEcCtD
Adenosine—Dizziness—Prednisone—systemic scleroderma	8.95e-05	0.000711	CcSEcCtD
Adenosine—Vomiting—Prednisone—systemic scleroderma	8.61e-05	0.000684	CcSEcCtD
Adenosine—Rash—Prednisone—systemic scleroderma	8.54e-05	0.000678	CcSEcCtD
Adenosine—Dermatitis—Prednisone—systemic scleroderma	8.53e-05	0.000678	CcSEcCtD
Adenosine—Headache—Prednisone—systemic scleroderma	8.48e-05	0.000674	CcSEcCtD
Adenosine—Hypersensitivity—Methotrexate—systemic scleroderma	8.33e-05	0.000662	CcSEcCtD
Adenosine—Asthenia—Methotrexate—systemic scleroderma	8.12e-05	0.000645	CcSEcCtD
Adenosine—Nausea—Prednisone—systemic scleroderma	8.04e-05	0.000639	CcSEcCtD
Adenosine—Dizziness—Methotrexate—systemic scleroderma	7.48e-05	0.000595	CcSEcCtD
Adenosine—Vomiting—Methotrexate—systemic scleroderma	7.19e-05	0.000572	CcSEcCtD
Adenosine—Rash—Methotrexate—systemic scleroderma	7.13e-05	0.000567	CcSEcCtD
Adenosine—Dermatitis—Methotrexate—systemic scleroderma	7.13e-05	0.000566	CcSEcCtD
Adenosine—Headache—Methotrexate—systemic scleroderma	7.09e-05	0.000563	CcSEcCtD
Adenosine—Nausea—Methotrexate—systemic scleroderma	6.72e-05	0.000534	CcSEcCtD
